Giovannoni Isabella, Callea Francesco, Travaglini Lorena, Amodeo Antonio, Cogo Paola, Secinaro Aurelio, Bizzarri Carla, Cutrera Renato, El Hachem May, Francalanci Paola
Department of Pathology and Molecular Histopathology, Bambino Gesù Children's Hospital, IRCCS, Rome Piazza Sant'Onofrio, 4 00165, Rome, Italy,
Eur J Pediatr. 2014 Dec;173(12):1735-40. doi: 10.1007/s00431-014-2447-7. Epub 2014 Nov 1.
Generalized arterial calcification of infancy (GACI, OMIM 208000) and pseudoxanthoma elasticum (PXE, OMIM 264800) are rare autosomal-recessive disorders which represent the opposite ends of the same spectrum of pathologies characterized by progressive ectopic calcification and degeneration of elastic fibers at skin, eyes, and cardiovascular level. Patients with GACI suffer from hypertension, severe myocardial ischemia, and congestive heart failure and often die within 6 months of life. On the other end, PXE is associated with considerable morbidity, rarely with mortality. GACI and PXE are associated with biallelic mutations in ENPP1 and in ABCC6. We report the case of a 4-year-old Italian child submitted to heart transplant, at 18 months old, for end-stage heart failure due to extensive myocardial infarction of the left ventricle and diffuse coronary calcifications. The histology showed generalized arterial calcification and the molecular analysis identified mutations in ABCC6. Two years after transplantation, the child shows good clinical conditions and growth with no recurrence of calcium deposits in the heart.
Bisphosphonate therapy at present is the treatment of choice for systemic arterial involvement in GACI, and heart transplant has proven to be the definitive treatment in case with extensive myocardial infarction, as in our. Molecular analysis is mandatory for a complete diagnosis and familial counseling.
婴儿期全身性动脉钙化(GACI,OMIM 208000)和弹性假黄瘤(PXE,OMIM 264800)是罕见的常染色体隐性疾病,它们代表了同一病理谱的两端,其特征是皮肤、眼睛和心血管水平的弹性纤维进行性异位钙化和退变。GACI患者患有高血压、严重心肌缺血和充血性心力衰竭,通常在出生后6个月内死亡。另一方面,PXE与相当高的发病率相关,很少与死亡率相关。GACI和PXE与ENPP1和ABCC6的双等位基因突变有关。我们报告了一例4岁意大利儿童的病例,该儿童在18个月大时因左心室广泛心肌梗死和弥漫性冠状动脉钙化导致终末期心力衰竭而接受心脏移植。组织学检查显示全身性动脉钙化,分子分析鉴定出ABCC6基因突变。移植两年后,该儿童临床状况良好且生长正常,心脏未再出现钙沉积。
目前,双膦酸盐疗法是GACI全身性动脉受累的首选治疗方法,正如我们的病例所示,心脏移植已被证明是广泛心肌梗死情况下的确定性治疗方法。分子分析对于完整诊断和家族咨询是必不可少的。